chr13-36346781-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000451493.5(SPART):c.-202G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 152,386 control chromosomes in the GnomAD database, including 5,246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5228 hom., cov: 32)
Exomes 𝑓: 0.40 ( 18 hom. )
Consequence
SPART
ENST00000451493.5 5_prime_UTR
ENST00000451493.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.150
Genes affected
SPART (HGNC:18514): (spartin) This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 13-36346781-C-G is Benign according to our data. Variant chr13-36346781-C-G is described in ClinVar as [Benign]. Clinvar id is 1526321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-36346781-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPART | NM_001142294.2 | c.-2-10949G>C | intron_variant | NP_001135766.1 | ||||
SPART-AS1 | NR_045180.1 | n.77+274C>G | intron_variant | |||||
SPART-AS1 | NR_045181.1 | n.77+274C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPART | ENST00000451493.5 | c.-202G>C | 5_prime_UTR_variant | 1/9 | 1 | ENSP00000414147.1 | ||||
SPART | ENST00000355182.8 | c.-2-10949G>C | intron_variant | 5 | ENSP00000347314.4 | |||||
SPART | ENST00000650221.1 | c.-2-10949G>C | intron_variant | ENSP00000497209.1 |
Frequencies
GnomAD3 genomes AF: 0.248 AC: 37763AN: 152066Hom.: 5232 Cov.: 32
GnomAD3 genomes
AF:
AC:
37763
AN:
152066
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.401 AC: 81AN: 202Hom.: 18 Cov.: 0 AF XY: 0.375 AC XY: 57AN XY: 152
GnomAD4 exome
AF:
AC:
81
AN:
202
Hom.:
Cov.:
0
AF XY:
AC XY:
57
AN XY:
152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.248 AC: 37775AN: 152184Hom.: 5228 Cov.: 32 AF XY: 0.250 AC XY: 18618AN XY: 74408
GnomAD4 genome
AF:
AC:
37775
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
18618
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1399
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at